FDA Gives Nod to Aflibercept for Colon Cancer
(MedPage Today) — The FDA has approved the angiogenesis inhibitor aflibercept (Zaltrap) for patients with previously treated metastatic colorectal cancer.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com